Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

280.32
Delayed Data
As of 4:00pm ET
 -0.25 / -0.09%
Today’s Change
205.42
Today|||52-Week Range
307.33
+7.32%
Year-to-Date
Seeking Value in Biotech: Biogen
Jun 22 / GuruFocus News - Paid Partner Content
Nektar (NKTR) Stock Rallied Almost 50% This Year: Here's Why
Jun 16 / Zacks.com - Paid Partner Content
Pharma recovers composure as price concerns ease
Jun 21 / FT.com - Paid Partner Content
Bear of the Day: Bioverativ (BIVV)
Jun 16 / Zacks.com - Paid Partner Content
Biogen Ready for a Big Bounce
Jun 21 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug
Jun 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
Biogen Loses Top Executive Again, CFO Clancy to Join Alexion
Jun 14 / Zacks.com - Paid Partner Content
Biogen Upgraded at UBS on Alzheimer's Clinical Trial Progress
Jun 19 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close280.57
Today’s open282.33
Day’s range277.58 - 284.46
Volume2,439,562
Average volume (3 months)1,641,961
Market cap$59.5B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+1.40%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+9.37%
P/E ratio17.6
Price/Sales6.09
Price/Book4.99

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.04+0.06%
ILMNIllumina Inc+2.29+1.25%
BIVVBioverativ Inc+1.60+2.62%
KITEKite Pharma Inc+6.67+7.10%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$4.54
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
VP-Finance, Chief Financial &
Accounting Officer
Gregory F. Covino
Corporate headquarters
Cambridge, Massachusetts

Forecasts